Doç. Dr.İbrahim Koral Önal

  • İlgi Alanları
  • Karaciğer kanseri
  • Hepatit B
  • Hepatit C
  • Reflü
  • Çölyak
  • ERCP
  • Obezite
  • Mide botoksu

Eğitim ve Uzmanlık
1994 - 2001 - Hacettepe Üniversitesi Tıp Fakültesi (İngilizce)
2001 - 2006 - Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları ABD
2008 - 2011 - Türkiye Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Gastroenteroloji Yan Dal Uzmanlık
2012 - Ankara Abdurrhaman Yurtarslan Eğitim ve Araştırma Hastanesİ Doçentlik 

Deneyim
Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları ABD / Arş Görevlisi
Şanlıurfa Devlet Hastanesi / Mecburi Hizmet  / İç Hastalıkları Uzmanı
Ankara Abdurrhaman Yurtarslan Eğit ve Araşt Hast/ Mecburi Hizmet / İç Hastalıkları Uzmanı
Türkiye Yüksek İhtisas Eğitim ve Araştırma Hastanesi / İç Hastalıkları Uzmanı ve Gastroenteroloji Asistanı
Diyarbakır Asker Hastanesi / Gastroenteroloji Uzmanı
Çankırı Devlet Hastanesi / Mecburi Hizmet / Gastroenteroloji Uzmanı
Ankara Abdurrhaman Yurtarslan Eğit ve Araştırma Hastanesi / Mecburi Hizmet / Gastroenteroloji  Uzmanı -Doçent
Gazi Üniversitesi Tıp Fakültesi (İç Hastalıkları ABD / Gastroenteroloji BD) / Gastroenteroloji Doçenti

Mesleki Üyelikler
Hepato Bilio Pankreatoloji Derneği
Türk Gastroenteroloji Derneği
Türk İç Hastalıkları Uzmanlık Derneği
Kocaeli Tabip Odası

Ödüller
1992 Tübitak Bilim Olimpiyatları Akdeniz Bölge Birinciliği
1994 Özel Antalya Koleji Fen Lisesi Üçüncülük derecesi ile mezuniyet
1999 Şeref Zileli Hacettepe İç Hastalıkları Yılın Başarılı Stajyer Öğrenci Ödülü
2001 Hacettepe Üniversitesi Tıp Fakültesi (İng) nden İlk On Derece İçinde Mezuniyet
2005 Şeref Zileli Hacettepe İç Hastalıkları Yılın Başarılı Asistanı Ödülü
2005 Türk İç Hastalıkları Uzmanlık Derneği Yeterlilik (Board) Sınavında Yeterlilik
2007 OSYM Sonbahar Dönemi Yan Dal Uzmanlık Sınavı Türkiye Üçüncülüğü

Yurt içi ve yurt dışı dergilerde 120 adet makalesi ve 1000 in üzerinde atıfı bulunmaktadır. “h” indeksi 18 dir. ". Eserlerinden bazıları:

  • I.K. Onal, Beyazit Y, Altinbas A, Kurt M, Arhan M (2015). Maintenance therapy for Crohn's disease: should it be indefinite?. European Journal of Gastroenterology and Hepatology, 27 (10)(1115-25).
  • I.K. Onal, Kekilli M, Tanoglu A, Erdal H, Ibis M, Arhan M (2015). Tuberculosis and Crohn's Disease Revisited. Journal of College of Physicians and Surgeons of Pakistan, 25(6)(443-8).
  • I.K.Onal. Endothelial dysfunction in patients with non-alcoholic steatohepatitis. Ups J Med Sci. [Epub ahead of print] (2014).
  • I.K. Onal . Folate deficiency in Crohn's disease. Scand J Gastroenterol. Feb;49(2):253-4 (2014).
  • I.K. Onal. Effect of steroid sparing agents on the clinical course of ulcerative colitis. Eur J Intern Med. Feb;25(2):e19 (2014).
  • I.K.Onal, H.Gokcan, E.Benzer, G.Bilir, E.Oztas (2013). What Is the impact of Helicobacter Pylori density on the success of eradication therapy: A clinico-histopathological study . Clinics and Research in Hepatology and Gastroenterology , 37(642-6).
  • I.K.Onal, E.Parlak, M.Akdogan, Y.Yesil, S.O.Kuran, M.Kurt, S.Disibeyaz, E.Ozturk, B.Odemis (2013). Do aspirin and non-steroidal anti-inflammatory drugs increase the risk of post-sphincterotomy hemorrhage - A case-control study. Clinics and Research in Hepatology and Gastroenterology, 37(171-6).
  • I.K. Onal. Serum angiotensin-converting enzyme level as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. J Renin Angiotensin Aldosterone Syst. Sep;14(3):283 (2013).
  • I.K. Onal. Diagnostic testing for Helicobacter Pylori in patients with atrophic gastritis. Clin Res Hepatol Gastroenterol. Nov;37(5):e115-6. (2013).
  • I.K.Onal, Y.Beyazit, B.Sener, B.Savuk, D.O.Etik, A.Sayilir, E.Oztas, S.Torun, Y.O. Ozin, B.T.Demirel, A.Ulker, U.Dagli (2012). The Value of Fecal Calprotectin as a Marker of Intestinal Inflammation in Patients with Ulcerative Colitis. Turkish Journal of Gastroenterology , 23(509-14).
  • I.K.Onal, E.Parlak, M.Kekilli, M.Kurt, Habibe Alioglu, S.Disibeyaz, A.Sayılır, Y.Beyazıt, N.Şaşmaz. (2012). Hepatitis B and C Virus Infection and Cholangiocarcinoma: A Case-Control Study in Turkey. International Journal of Hematology and Oncology , 24(187-91).
  • I.K.Onal, M.Akdogan, M.Arhan, Z.M.Yalinkilic, B.Cicek, S.Kacar, M.Kurt, M.Ibıs, Y.O.Ozin, A.Sayilir, N.Sasmaz (2012). Double balloon enteroscopy: a 3 year experience at a tertiary care center. Hepatogastroenterology, 59(1851-4).
  • M.Kurt, I.K.Onal, A.Y.Sayilir, Y.Beyazit, E.Oztas, M.Kekilli, N.Turhan, K.Karaman , M.Akdogan. (2012). The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology, 59(1580-2).
  • I.K.Onal, M.Akdogan, E.Oztas, M.Balci, M.Kurt, S.Kacar, S.O.Kuran, N.Karabiber, N.Sasmaz. (2011). Does interleukin-18 play a role in the pathogenesis of hepatic encephalopathy?. Hepatogastroenterology, 58(497-502).
  • I.K.Onal, M.Arhan, Y.O.Ozın, A.Tas, S.Sezer, B.T.Demirel, A.Ulker (2011). Efficacy and safety of azathioprine therapy in Turkish patients with inflammatory bowel disease: A retrospective long term follow up study. Turkiye Klinikleri Tıp Bilimleri Dergisi, 31(568-74).
  • M.Arhan, I.K.Onal, A.Tas, M.Kurt, I.H.Kalkan, Y.Ozin, B.Tunc, A.Ulker. (2011). The role of red cell distribution width as a marker in inflammatory bowel disease. Turkish Journal of Medical Sciences , 41(227-34).
  • B.T.Demirel, M.Kekilli, I.K.Onal, E.Parlak, S.Disibeyaz, S.Kacar, Z.M.Kilic, N.Sasmaz, B.Sahin. (2011). ERCP experience in patients with choledochoduodenostomy: diagnostic findings and therapeutic management. Surgical Endoscopy, 25(1043-7).
  • M.Kurt, I.K.Onal, E.Parlak, A.Shorbagi, M.Kekilli, M.Ibis, M.Hayran, N.Sasmaz. (2010). Do metabolic alterations serve as biochemical markers in the diagnosis of malignant biliary obstruction? An observational study.. European Journal of Gastroenterology and Hepatology , 22(58-60).
  • M.Kurt, I.Onal, M.Akdogan, M.Kekilli, M.Arhan, A.Sayilir, E.Oztas, I.Haznedaroglu (2010). Ankaferd blood stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures.. Canadian Journal of Gastroenterology , 24(380-4).
  • I.K.Onal, Nessar G, Yardimci S, Turhan N, Kurt M, Ulker A. Recent-onset ulcerative colitis complicated by colon ischemia in an elderly patient. J Am Geriatr Soc. Jul;58(7):1417-8. (2010).
  • I.K.Onal, C.Sokmensuer, E.D.Onal, O.Ersoy, O.Yeniova, M.Aydinli, O.Yonem, O.Harmanci, Y.Bayraktar, F.Batman (2009). Clinical and pathological features of nodular gastritis in adults. Turkish Journal of Medical Sciences , 39(719-723).
  • I.K.Onal, B.Altun, E.D.Onal, A.Kirkpantur, S.Gul Oz, C.Turgan. (2009). Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment. European Journal of Internal Medicine, 20(369-72).
  • C.Sokmensuer, I.K.Onal, O.Yeniova, O.Ersoy, M.Aydinli, O.Yonem, O.Harmanci, E.D.Onal, G.Altinok, F.Batman, Y.Bayraktar. (2009). What are the clinical implications of nodular gastritis? Clues from histopathology.. Digestive Diseases and Sciences , 54(2150-4).
  • I.K. Onal, Turhan N, Oztas E, Arhan M, Akcoren Z, Oguz P, Akdogan M, Onal ED, Kacar S, Kurt M, Sasmaz N. Hepatocellular carcinoma in an adult patient with type IV glycogen storage disease. Acta Gastroenterol Belg. Jul-Sep;72(3):377-8 (2009).
  • I.K.Onal, Kurt M, Akdogan M, Kalkan IH, Kiremitci S, Odemis B, Oguz D, Sasmaz N. A rare cause of upper gastrointestinal bleeding: stromal tumor of duodenum masquerading as papilla vateri. Am J Gastroenterol. Feb;104(2):535 (2009).
  • I.K.Onal, O.Ersoy, M.Aydinli, O.Yonem, O.Harmanci, C.Sokmensuer, Y.Bayraktar. (2008). Hepatic granuloma in Turkish adults: a report of 13 cases. European Journal of Internal Medicine, 19(527-30).
  • O.Dizdar, I.K.Onal, E.Ozakin, E.Karakiliç, O.Karadag, U.Kalyoncu, F.Coşkun, Y.Buyukasik. (2007). Research for bleeding tendency in patients presenting with significant epistaxis. Blood Coagulation and Fibrinolysis , 18(41-3).
  • I.K.Onal, M.Cankurtaran, M.Cakar , M.Halil, Z.Ulger, B.B.Doğu, O.Uzun, S.Unal, S.Arioğul. (2006). Fever of unknown origin: what is remarkable in the elderly in a developing country?. Journal of infection, 52(399-404).
  • I.K. Onal, Dağdelen S, Atmaca A, Karadağ O, Adalar N. Hemorrhage into a thyroid nodule as a cause of thyrotoxicosis. Endocr Pract. May-Jun;12(3):299-301 (2006).
  • I.K.Onal, Shorbagi A, Göker H, Büyükasýk Y, Ozçakar L, Tufan A, Aksu S, Haznedaroglu YC. Cauda equina syndrome as a rare manifestation of leukemia relapse during postallograft period. J Natl Med Assoc. May;98(5):808-10 (2006).
  • I.K. Onal, Bayraktar Y, Unal S. Paradoxical deterioration during the course of antituberculous treatment. J Natl Med Assoc. Jun;98(6):954-5 (2006).
  • I.K.Onal, Kurt M, Altundag K, Aksoy S, Dincer M, Gullu I. Peripheral T-cell lymphoma and Job's syndrome: a rare association. Med Oncol. 23(1):141-4 (2006).
  • I.K.Onal, Ozçakar L, Dizdar O, Büyükaşik Y, Dündar S. Seropositive arthritis in chronic lymphocytic leukemia: a remark on B cell-mediated autoimmunity. Rheumatol Int. Sep;25(7):569-70 (2005).
  • I.K.Onal, Sümer H, Tufan A, Shorbagi A. Bone marrow embolism after bone marrow aspiration and biopsy. Am J Hematol. Feb;78(2):158 (2005).

I.K. Onal, Ozçakar L, Temirel K, Aran R, Kurt M. Fatal endocarditis in Wegener's granulomatosis: mitral valve involvement and an intracardiac mass. Joint Bone Spine. Dec;72(6):585-7 (2005).